"NCT01349881" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "18"^^ . . . . . . . . . . . . . . . . . . . "clinical trial"@en . . . . . . . . . . . . . . . . . . . . "1340"^^ . . . . . . . . . . . . . . . . . "PACES"@en . . . . . . . . . . . . "\u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0435 \u0432\u0438\u043F\u0440\u043E\u0431\u0443\u0432\u0430\u043D\u043D\u044F"@uk . . . . "ensayu cl\u00EDnicu"@ast . . . . . . . . . "2013-03-01T00:00:00Z"^^ . . "S0820, Adenoma and Second Primary Prevention Trial"@en . . . . . . . . . . "2025-07-01T00:00:00Z"^^ . . . . . . . . . . . . . . . . . . . . "S0820, Adenoma and Second Primary Prevention Trial"@en . . . . . "A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients With Stage 0-III Colon or Rectal Cancer, Phase III - Preventing Adenomas of the Colon With Eflornithine and Sulindac (PACES)"@en . . . "klinisch onderzoek"@nl . . . "S0820, Adenoma and Second Primary Prevention Trial"@en . . . . .